Want to join the conversation?
James Medvedeff of Cowen & Company probes on SG&A, if the company is going to keep it flat YoverY, including EyeLock. $VOXX said the company had a lot of one-time expenses in the year that will not repeat. So the company thinks that those expenses could go a long way in covering the added expense from EyeLock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?